Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Ocular Drug Delivery Technology Market to 2025 by Technology, Indication & Geography - Research and Markets

Research and Markets
Posted on: 30 Nov 17

The "Global Ocular Drug Delivery Technology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to Research and Markets' offering.

The global ocular drug delivery technology market was valued at US$ 15,500 Mn in 2016, and is expected to reach US$ 25,697 Mn by 2025, expanding at a CAGR of 5.81% from 2017 to 2025.

Ocular drug delivery technology market is growing owing to rising prevalence of eye disorders. The complex of eye anatomy makes the treatment to be very challenging, hence innovations in ophthalmic treatment is still emerging with potential benefits. Presently available therapies not proven to be sufficient to treat every possible sites of eye, therefore enhanced product formulation with improved technology became vital.

According to the statistics of World Health Organizations, 285 million people are visually impaired across the world and this global burden of eye disorder is increasing with rapidly growing ageing population. WHO has taken an initiative named VISION 2020 to abolish the possible causes of blindness and provide better eye-care infrastructure to make easily accessible eye-care.

The ocular drug delivery technology market is predicted to experience substantial growth due to growing elderly population, increasing medical interventions and increasing prevalence of eye diseases. The increasing adoption of technologically advanced products, healthcare expenditure for R&D to develop innovative products boost up the growth of the ocular drug delivery technology market.

Key Market Movements:

  • The rising prevalence of eye disorder, growing ageing population, rising public awareness, increasing number of medical intervention, expanding eye-care set up to reduce global burden of eye diseases, increasing healthcare expenditure for R&D to manufacture newer and innovative products boost up the growth of ocular drug delivery technology market.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

  • Ocular Drug Delivery Technology Market Portraiture
  • Ocular Drug Delivery Technology Market, by Technology Type, 2016 (US$ Mn)
  • Ocular Drug Delivery Technology Market, by Indication Type, 2016 (US$ Mn)
  • Ocular Drug Delivery Technology Market, by Geography, 2016 (Value %)

Chapter 3 Global Ocular Drug Delivery Technology Market Analysis

  • Global Ocular Drug Delivery Technology Market Overview
  • Market Dynamics
  • Attractive Investment Proposition
  • Competitive Analysis: Global Ocular Drug Delivery Technology Market, 2016 (Value %)

Chapter 4 Global Ocular Drug Delivery Technology Market Analysis, By Technology Type

  • Topical Medication
  • Ocular Insert
  • Ocular Implant

Chapter 5 Global Ocular Drug Delivery Technology Market Analysis, By Indication Type

  • Glaucoma
  • Age Related Macular Degeneration

Chapter 6 Global Ocular Drug Delivery Technology Market, By Geography

Chapter 7 Company Profiles

  • Alimera Sciences
  • Valeant Pharmaceuticals International, Inc.
  • Ocular Therapeutix
  • Allergan, Plc.
  • Clearside Biomedical
  • EyeGate Pharma
  • Envisia Therapeutics, Inc.
  • Graybug Vision Inc.

For more information about this report visit https://www.researchandmarkets.com/research/cvzfh6/global_ocular

View source version on businesswire.com: http://www.businesswire.com/news/home/20171130005604/en/

Business Wire
www.businesswire.com

Last updated on: 30/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.